Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial...
Q2 2026
Aug 10, 2026
Q1 2026
May 7, 2026
FY 2025
Mar 26, 2026
Q4 2025
Mar 26, 2026
Q3 2025
Nov 5, 2025